{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:42:23Z","timestamp":1783615343372,"version":"3.55.0"},"reference-count":40,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Trials for additional or alternative treatments for cervical dystonia (CD) are scarce since the introduction of botulinum neurotoxin (BoNT). We performed the first trial to investigate whether dystonic jerks\/tremor in patients with CD respond to the selective serotonin reuptake inhibitor (SSRI) escitalopram.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In a randomised, double-blind, crossover trial, patients with CD received escitalopram and placebo for 6 weeks. Treatment with BoNT was continued, and scores on rating scales regarding dystonia, psychiatric symptoms and quality of life (QoL) were compared. Primary endpoint was the proportion of patients that improved at least one point on the Clinical Global Impression Scale for jerks\/tremor scored by independent physicians with experience in movement disorders.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fifty-threepatients were included. In the escitalopram period, 14\/49 patients (29%) improved on severity of jerks\/tremor versus 11\/48 patients (23%) in the placebo period (P=0.77). There were no significant differences between baseline and after treatment with escitalopram or placebo on severity of dystonia or jerks\/tremor. Psychiatric symptoms and QoL improved significantly in both periods compared with baseline. There were no significant differences between treatment with escitalopram and placebo for dystonia, psychiatric or QoL rating scales. During treatment with escitalopram, patients experienced slightly more adverse events, but no serious adverse events occurred.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this innovative trial, no add-on effect of escitalopram for treatment of CD with jerks was found on motor or psychiatric symptoms. However, we also did not find a reason to withhold patients treatment with SSRIs for depression and anxiety, which are common in dystonia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p>NTR2178.<\/jats:p><\/jats:sec>","DOI":"10.1136\/jnnp-2017-317352","type":"journal-article","created":{"date-parts":[[2018,8,4]],"date-time":"2018-08-04T13:35:31Z","timestamp":1533389731000},"page":"579-585","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["Randomised controlled trial of escitalopram for cervical dystonia with dystonic jerks\/tremor"],"prefix":"10.1136","volume":"89","author":[{"given":"Evelien","family":"Zoons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Booij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine C S","family":"Delnooz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke M","family":"Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine E M","family":"Dreissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes H T M","family":"Koelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra M A","family":"van der Salm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matej","family":"Skorvanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marenka","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Aramideh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Bienfait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnita J W","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen W M","family":"Brans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edo","family":"Hoogerwaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad","family":"Hovestadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan J","family":"Kamphuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G","family":"Munts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes D","family":"Speelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina A J","family":"Tijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,1,11]]},"reference":[{"key":"2020050722301615000_89.6.579.1","doi-asserted-by":"publisher","DOI":"10.1007\/s004150070094"},{"key":"2020050722301615000_89.6.579.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2013.02.017"},{"key":"2020050722301615000_89.6.579.3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.parkreldis.2016.06.004","article-title":"Psychiatric co-morbidity is highly prevalent in idiopathic cervical dystonia and significantly influences health-related quality of life: Results of a controlled study","volume":"30","author":"Smit","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"2020050722301615000_89.6.579.4","first-page":":95","article-title":"Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections","volume":"22","author":"Slawek","year":"2007","journal-title":"Funct Neurol"},{"key":"2020050722301615000_89.6.579.5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fneur.2017.00035","article-title":"Clinical Practice: evidence-based recommendations for the treatment of cervical dystonia with botulinum Toxin","volume":"8","author":"Contarino","year":"2017","journal-title":"Front Neurol"},{"key":"2020050722301615000_89.6.579.6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-000881"},{"key":"2020050722301615000_89.6.579.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2232-7"},{"key":"2020050722301615000_89.6.579.8","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00259-017-3664-x","article-title":"The relationship between the dopaminergic system and depressive symptoms in cervical dystonia","volume":"44","author":"Zoons","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2020050722301615000_89.6.579.9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13550-017-0338-4","article-title":"Lower serotonin transporter binding in patients with cervical dystonia is associated with psychiatric symptoms","volume":"7","author":"Zoons","year":"2017","journal-title":"EJNMMI Res"},{"key":"2020050722301615000_89.6.579.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(02)00338-X"},{"key":"2020050722301615000_89.6.579.11","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv215"},{"key":"2020050722301615000_89.6.579.12","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neubiorev.2016.03.015","article-title":"Serotonergic perturbations in dystonia disorders-a systematic review","volume":"65","author":"Smit","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"2020050722301615000_89.6.579.13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000449184","article-title":"Tetrabenazine: spotlight on drug review","volume":"23","author":"Kaur","year":"2016","journal-title":"Ann Neurosci"},{"key":"2020050722301615000_89.6.579.14","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000023"},{"key":"2020050722301615000_89.6.579.15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jpba.2016.08.014","article-title":"Stereoselective determination of citalopram and desmethylcitalopram in human plasma and breast milk by liquid chromatography tandem mass spectrometry","volume":"131","author":"Weisskopf","year":"2016","journal-title":"J Pharm Biomed Anal"},{"key":"2020050722301615000_89.6.579.16","doi-asserted-by":"publisher","DOI":"10.1002\/nur.4770130405"},{"key":"2020050722301615000_89.6.579.17","first-page":"20","article-title":"Pretreatment status and its relationship to the length of drying-out period","volume":"12","author":"Guy","year":"1976","journal-title":"Psychopharmacol Bull"},{"key":"2020050722301615000_89.6.579.18","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870120117"},{"key":"2020050722301615000_89.6.579.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)18475-8"},{"key":"2020050722301615000_89.6.579.20","first-page":"361","article-title":"The unified myoclonus rating scale","volume":"89","author":"Frucht","year":"2002","journal-title":"Adv Neurol"},{"key":"2020050722301615000_89.6.579.21","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20403"},{"key":"2020050722301615000_89.6.579.22","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s004150170028","article-title":"Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study","volume":"248","author":"Wissel","year":"2001","journal-title":"J Neurol"},{"key":"2020050722301615000_89.6.579.23","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.parkreldis.2015.04.018","article-title":"Antidepressive treatments for Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"21","author":"Bomasang-Layno","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"2020050722301615000_89.6.579.24","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq268"},{"key":"2020050722301615000_89.6.579.25","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v57n1002"},{"key":"2020050722301615000_89.6.579.26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/mds.22983","article-title":"Psychiatric disorders in adult-onset focal dystonia: a case-control study","volume":"25","author":"Fabbrini","year":"2010","journal-title":"Mov Disord"},{"key":"2020050722301615000_89.6.579.27","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23906"},{"key":"2020050722301615000_89.6.579.28","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21764"},{"key":"2020050722301615000_89.6.579.29","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25501"},{"key":"2020050722301615000_89.6.579.30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.NMD.0000081667.02656.21","article-title":"High psychiatric comorbidity in spasmodic torticollis: a controlled study","volume":"191","author":"G\u00fcndel","year":"2003","journal-title":"J Nerv Ment Dis"},{"key":"2020050722301615000_89.6.579.31","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.170191"},{"key":"2020050722301615000_89.6.579.32","doi-asserted-by":"publisher","DOI":"10.1002\/da.10039"},{"key":"2020050722301615000_89.6.579.33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s12640-012-9314-y","article-title":"Efficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: a systematic review","volume":"22","author":"Colosimo","year":"2012","journal-title":"Neurotox Res"},{"key":"2020050722301615000_89.6.579.34","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-002-0733-1"},{"key":"2020050722301615000_89.6.579.35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050045"},{"key":"2020050722301615000_89.6.579.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2013.07.009"},{"key":"2020050722301615000_89.6.579.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-4328(02)00130-4"},{"key":"2020050722301615000_89.6.579.38","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00415-014-7244-8","article-title":"Psychiatric disorders in idiopathic-isolated focal dystonia","volume":"261","author":"Lehn","year":"2014","journal-title":"J Neurol"},{"key":"2020050722301615000_89.6.579.39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/bcp.12348","article-title":"Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations","volume":"78","author":"Ji","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"2020050722301615000_89.6.579.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2013.10.002"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2017-317352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T18:09:23Z","timestamp":1601057363000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2017-317352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,11]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,5,24]]},"published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1136\/jnnp-2017-317352"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2017-317352","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,11]]}}}